Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Guidance

Subcategories:Clinical Criteria/GuidelinesEthicsLegal UpdatesLegislation & AdvocacyMeeting ReportsResearch Rheum

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

High-resolution computed tomography shows evidence of ILD.

The ACR/CHEST ILD Guidelines in Practice, a video
In collaboration with the American College of Chest Physicians, the ACR released two new comprehensive guidelines aimed at improving the screening, monitoring, and treatment of patients with interstitial lung disease (ILD) secondary to systemic autoimmune rheumatic diseases (SARDs). Recently, Sindhu R. Johnson, MD, PhD, professor of medicine at the University of Toronto, Canada, director of the Toronto Scleroderma Program and principal investigator for the guideline, and Elana J. Bernstein, MD, MSc, Florence Irving associate professor of medicine in the Division of Rheumatology at Columbia University, New York City, and co-first author, presented a webinar to talk about how the guidelines were developed and present some of the recommendations and their rationale: Watch the recording now!

 

Triple-Threat Rheumatologist H. Ralph Schumacher, Jr., MD, Has a Zest for Research

Gretchen Henkel  |  January 1, 2010

H. Ralph Schumacher, Jr., MD, has a zest for research

Reach Out To Local Media to Promote Rheumatology

From the College  |  January 1, 2010

The ACR is committed to advocating on behalf of its members. This could be on Capitol Hill, by working with insurance providers, or by working with the media to promote the work of rheumatologists and rheumatology health professionals and advance the issues affecting them.

Without You, ACR REF Wouldn’t Be Here

From the College  |  January 1, 2010

In 1998, the ACR Research and Education Foundation (REF) funded a total of $500,000 in grants. This year, the REF funded more than $4.6 million in grants through its core portfolio, which is an increase of over $4 million in funding capabilities in just 10 years. The REF also achieved the distinction of becoming the second largest funding source—just behind the National Institutes of Health (NIH)—of rheumatology research and training programs in the United States and was recently awarded the prestigious four-star rating from Charity Navigator. These achievements could not have been realized without the generous financial support of REF donors.

ACR Delegates Attend AMA House of Delegates Interim Meeting

Staff  |  January 1, 2010

The 2009 Interim Meeting of the American Medical Association (AMA) House of Delegates was held November 7–10, 2009, in Houston. AMA Delegate Gary Bryant, MD, and AMA Alternate Delegate Eileen Moynihan, MD, represented the ACR.

Philadelphia Displays Many Facets of the Healthcare Debate

David S. Pisetsky, MD, PhD  |  January 1, 2010

City of Brotherly Love displays many facets of the healthcare debate

Reading Rheum

Staff  |  December 1, 2009

Handpicked Reviews of Contemporary Literature

RheumPAC Supports Those Who Support Rheumatology

Staff  |  December 1, 2009

RheumPAC, the ACR’s Political Action Committee, ensures that the ACR is involved in healthcare reform discussions. RheumPAC representatives have been busy attending fundraisers and educating key congressional members on the ACR’s legislative priorities.

Rep. Allyson Schwarz Speaks at Annual Meeting

Staff  |  December 1, 2009

Representative Allyson Schwarz (D-Pa.) held a Healthcare Legislative Update at the 2009 Annual Scientific Meeting in Philadelphia, held in October. Rep. Schwartz spoke to a group of rheumatology professionals about the different healthcare proposals currently before Congress. As a key member of the House Ways and Means Committee, Rep. Schwartz gave an insider’s view of the healthcare reform debate going on in the House. She was interested in the perspective of the rheumatology community and took questions from the audience. Members of the audience asked the Representative about issues important to rheumatologists, such as access to care, elimination of the sustainable growth rate formula, and medical liability reform.

Building on Accomplishments

E. William St.Clair, MD  |  December 1, 2009

As I assume the presidency of the REF, I reflect on the accomplishments of the organization over the past two years, and I wish to thank my immediate predecessor, Leslie J. Crofford, MD, for her tremendous leadership. The achievements of the REF during her term have been truly impressive.

A Preceptorship Comes Full Circle

Staff  |  December 1, 2009

Ephraim P. Engleman, MD, has spent his career drawing attention to the field of rheumatology. Widely regarded as one of the founders of the modern practice of rheumatology, this 98-year-old director of the Rosalind Russell Medical Research Center for Arthritis at the University of California, San Francisco (UCSF), is still working hard at promoting the field.

  • « Previous Page
  • 1
  • …
  • 283
  • 284
  • 285
  • 286
  • 287
  • …
  • 309
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences